Stockreport

Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger [Yahoo! Finance]

Salarius Pharmaceuticals, Inc.  (SLRX) 
PDF manufacturing of innovative peptide conjugate therapeutics through its IMP ACT™ platform Combined company has pro forma cash of $14 million following merger and closin [Read more]